| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.065 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |